Ebglyss 00002-7797
Generic: Lebrikizumab-Lbkz
Product NDC
00002-7797- Manufacturer
- Eli Lilly And Company
- Dosage Form
- Injection, Solution
- Route
- Subcutaneous
- Product Type
- Human Prescription Drug
- Marketing Start
- September 13, 2024
- Listing Expires
- December 31, 2027
- Application
- BLA761306
Need to source Ebglyss? Find it on a pharmacy-to-pharmacy marketplace at better prices.
✓ DSCSA Compliant. ✓ Verified Pharmacies Only.P2P pharmacy marketplace.
Active Ingredients
| Ingredient | Strength |
|---|---|
| Lebrikizumab | 250 mg/2mL |
Drug Class
Interleukin-13 Antagonist [EPC]Interleukin-13 Antagonist [EPC]Interleukin-13 Antagonists [MoA]
Packaging Options(2)
1 SYRINGE in 1 CARTON (0002-7797-11) / 2 mL in 1 SYRINGE (0002-7797-01)
1 SYRINGE in 1 CARTON (0002-7797-61) / 2 mL in 1 SYRINGE